SPLICING ALTERATIONS IN LOW RISK MYELODYSPLASTIC SYNDROME, TGF-B PATHWAY DEREGULATION IN SF3B1 MUTATED PATIENTS

被引：0
|
作者：
Hajrullaj, H. [1 ]
Onorato, A. [1 ]
Valenzuela, M. [1 ]
Cristiano, A. [1 ]
Silvestrini, G. [1 ]
Pieraccioli, M. [2 ]
Galossi, E. [1 ]
Falconi, G. [1 ]
Hutter, S. [3 ]
Nadarajah, N. [3 ]
Latagliata, R. [4 ,5 ]
Haferlach, T. [3 ]
Bielli, P. [1 ]
Voso, M. T. [1 ]
Fabiani, E. [1 ,6 ]
机构：
[1] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Milan, Italy
[3] MLL Munich Leukemia Lab, Munich, Germany
[4] Sapienza Univ, Unita Operat Complessa UOC Ematol, Osped Belcolle, Rome, Italy
[5] Sapienza Univ, Div Cellular Biotechnol & Hematol, Rome, Italy
[6] UniCamillus St Camillus Int Univ Hlth Sci, Rome, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C20
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [31] Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation
    Asou, Chie
    Maeda, Tomoya
    Ishikawa, Maho
    Okamura, Daisuke
    Kohri, Mika
    Takahashi, Naoki
    Tsukasaki, Kunihiro
    Sakaguchi, Hirozo
    Satoh, Tsugumi
    Kayano, Hidekazu
    Matsuda, Akira
    Asou, Norio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (06) : 898 - 901
  • [32] Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation
    Chie Asou
    Tomoya Maeda
    Maho Ishikawa
    Daisuke Okamura
    Mika Kohri
    Naoki Takahashi
    Kunihiro Tsukasaki
    Hirozo Sakaguchi
    Tsugumi Satoh
    Hidekazu Kayano
    Akira Matsuda
    Norio Asou
    International Journal of Hematology, 2022, 115 : 898 - 901
  • [33] Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
    H Dolatshad
    A Pellagatti
    M Fernandez-Mercado
    B H Yip
    L Malcovati
    M Attwood
    B Przychodzen
    N Sahgal
    A A Kanapin
    H Lockstone
    L Scifo
    P Vandenberghe
    E Papaemmanuil
    C W J Smith
    P J Campbell
    S Ogawa
    J P Maciejewski
    M Cazzola
    K I Savage
    J Boultwood
    Leukemia, 2015, 29 : 1092 - 1103
  • [34] Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
    Dolatshad, H.
    Pellagatti, A.
    Fernandez-Mercado, M.
    Yip, B. H.
    Malcovati, L.
    Attwood, M.
    Przychodzen, B.
    Sahgal, N.
    Kanapin, A. A.
    Lockstone, H.
    Scifo, L.
    Vandenberghe, P.
    Papaemmanuil, E.
    Smith, C. W. J.
    Campbell, P. J.
    Ogawa, S.
    Maciejewski, J. P.
    Cazzola, M.
    Savage, K. I.
    Boultwood, J.
    LEUKEMIA, 2015, 29 (05) : 1092 - 1103
  • [35] SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
    Furney, Simon J.
    Pedersen, Malin
    Gentien, David
    Dumont, Amaury G.
    Rapinat, Audrey
    Desjardins, Laurence
    Turajlic, Samra
    Piperno-Neumann, Sophie
    de la Grange, Pierre
    Roman-Roman, Sergio
    Stern, Marc-Henri
    Marais, Richard
    CANCER DISCOVERY, 2013, 3 (10) : 1122 - 1129
  • [36] SF3B1: from core splicing factor to oncogenic driver
    Bak-Gordon, Pedro
    Manley, James L.
    RNA, 2025, 31 (03) : 314 - 332
  • [37] Potential role of the splicing factor SF3B1 in epigenetic regulation
    Deliard, Sandra
    Okamoto, Yasuyuki
    Madzo, Jozef
    Jelinek, Jaroslav
    Issa, Jean-Pierre
    CANCER RESEARCH, 2017, 77
  • [38] IDENTIFICATION OF ALTERED AND CRYPTIC-SPLICING IN SF3B1 MUTANT MYELODYSPLASTIC SYNDROMES AND ISOGENIC MODELS OF SF3B1-K700E MUTATION
    Liberante, F.
    Lappin, K.
    Savage, K.
    Mills, K.
    HAEMATOLOGICA, 2016, 101 : 67 - 67
  • [39] SF3B1 Splicing Mutation in the Context of Therapy Related MDS
    Volpe, Virginia Olivia
    Al Ali, Najla
    Chan, Onyee
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2020, 136
  • [40] SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
    Lin, Chien-Chin
    Hou, Hsin-An
    Chou, Wen-Chien
    Kuo, Yuan-Yeh
    Wu, Shang-Ju
    Liu, Chieh-Yu
    Chen, Chien-Yuan
    Tseng, Mei-Hsuan
    Huang, Chi-Fei
    Lee, Fen-Yu
    Liu, Ming-Chih
    Liu, Chia-Wen
    Tang, Jih-Luh
    Yao, Ming
    Huang, Shang-Yi
    Hsu, Szu-Chun
    Ko, Bor-Sheng
    Tsay, Woei
    Chen, Yao-Chang
    Tien, Hwei-Fang
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (08) : E109 - E115
12345